The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Abeona Therapeutics Inc COM 00289Y107 9,351 2,859,767 SH   SOLE   2,859,767 0 0
Aldeyra Therapeutics Inc COM 01438T106 3,308 569,405 SH   SOLE   569,405 0 0
Anavex Life Sciences Corp COM NEW 032797300 1,876 724,205 SH   SOLE   724,205 0 0
Applied Therapeutics Inc COM 03828A101 12,742 467,071 SH   SOLE   467,071 0 0
Biohaven Pharmactl Hldg Co L COM G11196105 46,631 857,494 SH   SOLE   857,494 0 0
Blackstone Group LP COM UNIT LTD 09253U108 8,522 153,000 SH   SOLE   153,000 0 0
Catasys Inc COM PAR 149049504 702 43,034 SH   SOLE   43,034 0 0
Centurylink Inc COM 156700106 2,906 220,000 SH   SOLE   220,000 0 0
Corbus Pharmaceuticals HLDGS COM 21833P103 27,550 5,045,870 SH   SOLE   5,045,870 0 0
Corteva Inc COM 22052L104 887 30,000 SH   SOLE   30,000 0 0
Dow Inc COM 260557103 1,642 30,000 SH   SOLE   30,000 0 0
Dupont de Nemours Inc COM 26614N102 963 15,000 SH   SOLE   15,000 0 0
Eiger Biopharmaceuticals Inc COM 28249U105 5,219 350,238 SH   SOLE   350,238 0 0
Entera Bio Ltd SHS M40527109 3,605 1,741,363 SH   SOLE   1,741,363 0 0
Exicure Inc COM 30205M101 3,654 1,277,777 SH   SOLE   1,277,777 0 0
Kraneshares TR BOSERA MSCI CH 500767405 3,138 96,000 SH   SOLE   96,000 0 0
Molecular Templates COM 608550109 1,592 113,905 SH   SOLE   113,905 0 0
Soligenix Inc. COM 834223307 1,142 787,830 SH   SOLE   787,830 0 0